Regression of immunoproliferative small intestinal disease after eradication of Helicobacter pylori

Lancet

Volumn 349, Issue 9044, 1997, Pages 31-32

  Fischbach, Wolfgang ^a   Tacke, Wolfgang ^b   Greiner, Axel ^b   Konrad, Hans ^b   Muller Hermelink ^b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTINEOPLASTIC AGENT; CLARITHROMYCIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; IMMUNOGLOBULIN A; OMEPRAZOLE; PREDNISONE; TETRACYCLINE; VINBLASTINE; VINCRISTINE;

ADULT; ANTIMICROBIAL THERAPY; ARTICLE; B CELL LYMPHOMA; CASE REPORT; DUODENUM CANCER; HELICOBACTER PYLORI; HUMAN; INTESTINE LYMPHOMA; MALE; PATHOGENESIS; PRIORITY JOURNAL; REMISSION;

EID: 0031031840     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)62165-4     Document Type: Article

References (4)

1. Wotherspoon AC, Doglioni C, Diss TC, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993; 342: 575-77.
2. Bayerdörffer E, Neubauer A, Rudolph B, et al. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. Lancet 1995; 345: 1591-94.
3. Roggero E, Zucca E, Pinotti G, et al. Eradication of Helicobacter pylori infection in primary gastric low-grade gastric lymphoma of mucosa-associated lymphoid tissue. Ann Intern Med 1995; 122: 767-69.
4. Alkan S, Karcher DS, Newman MA, Cohen P. Regression of salivary gland MALT lymphoma after treatment for Helicobacter pylori. Lancet 1996; 348: 268-69.